WELLINGTON MANAGEMENT GROUP LLP - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$217,962,000
-7.1%
17,521,066
+2.2%
0.06%
-6.8%
Q3 2016$234,654,000
+13301.1%
17,140,492
+5616.7%
0.06%
Q3 2015$1,751,000
+60.6%
299,832
+127.5%
0.00%
Q2 2015$1,090,000
+409.3%
131,768
+323.7%
0.00%
Q4 2014$214,000
-10.1%
31,100
-29.5%
0.00%
Q3 2014$238,00044,1000.00%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,331,100$23,281,0008.28%
DAFNA Capital Management LLC 191,215$3,344,0004.89%
Redmile Group, LLC 1,277,109$22,337,0003.94%
BB BIOTECH AG 3,115,371$54,488,0003.92%
SECTORAL ASSET MANAGEMENT INC 5,292,682$92,569,0002.74%
IRONWOOD INVESTMENT MANAGEMENT LLC 565,956$9,899,0001.76%
OAK RIDGE INVESTMENTS LLC 2,645,781$46,275,0001.45%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,265,104$22,127,0001.04%
Tekla Capital Management LLC 412,965$7,223,0000.98%
Private Capital Advisors, Inc. 127,600$2,232,0000.83%
View complete list of ARIAD PHARMACEUTICALS INC shareholders